article thumbnail

PM360 Announces 2023 Trailblazer Award Finalists

PM360

Later in his career he transitioned to the agency side and launched Weisscom Partners in 2001, which ultimately evolved to Real Chemistry. Bigfoot Biomedical Ethicon, a Johnson & Johnson MedTech Company Medtronic Zimmer Biomet COMPANY OF THE YEAR: SPECIALTY PHARMA/BIOTECH argenx Chiesi GRD Cullinan Oncology, Inc. Tolstrup, Sr.

article thumbnail

PM360 Announces 2023 Trailblazer Award Winners

PM360

Later in his career he transitioned to the agency side and launched Weisscom Partners in 2001, which ultimately evolved into Real Chemistry. PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Tolstrup, Sr. Braun Medical, Inc.

article thumbnail

Rare Disease Day: Why raising awareness is essential for a fairer future

Pharmaceutical Technology

In the years between 2001-2010, a total of 1,527 designations were granted – almost triple the amount seen across the previous 17 years. Based on Pharmaceutical Technology’s analysis of GlobalData’s drugs database, a steep rise can be seen in the number of drugs receiving orphan drug designations in recent decades.